Sandhya Girish Selected Research

Sandhya Girish Research Topics

Disease

24	Breast Neoplasms (Breast Cancer) 04/2024 - 06/2010
19	Neoplasms (Cancer) 04/2024 - 02/2011
4	Body Weight (Weight, Body) 01/2021 - 05/2012
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2020 - 01/2020
4	Thrombocytopenia (Thrombopenia) 01/2015 - 06/2010
3	Stomach Neoplasms (Stomach Cancer) 01/2019 - 12/2017
2	COVID-19 11/2023 - 01/2021
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 12/2019
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 12/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 01/2018
2	Disease Progression 01/2019 - 01/2013
1	Triple Negative Breast Neoplasms 04/2024
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2021
1	Pathologic Complete Response 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2020
1	Lymphoid Leukemia 01/2020
1	Infections 01/2020
1	Neutropenia 01/2020
1	Carcinoma (Carcinomatosis) 12/2019
1	Hematologic Neoplasms (Hematological Malignancy) 11/2019
1	Diarrhea 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019
1	Brain Neoplasms (Brain Tumor) 08/2016
1	Nausea 06/2010
1	Fatigue 06/2010
1	Anemia 06/2010

Drug/Important Bio-Agent (IBA)

22	Ado-Trastuzumab EmtansineIBA 01/2019 - 06/2010
18	Immunoconjugates (Immunoconjugate)IBA 10/2020 - 06/2010
11	human ERBB2 proteinIBA 04/2024 - 02/2011
10	Trastuzumab (Herceptin)FDA Link 04/2022 - 02/2011
9	pertuzumabIBA 04/2022 - 10/2011
8	ErbB Receptors (EGF Receptor)IBA 01/2021 - 10/2011
5	polatuzumab vedotinIBA 12/2020 - 01/2020
4	AlbuminsIBA 04/2024 - 05/2012
4	Rituximab (Mabthera)FDA Link 12/2020 - 12/2019
3	atezolizumabIBA 12/2019 - 01/2018
3	Lapatinib (GW572016)FDA Link 04/2018 - 09/2012
3	Capecitabine (Xeloda)FDA Link 04/2018 - 09/2012
3	taxaneIBA 12/2017 - 09/2012
2	monomethyl auristatin EIBA 01/2020 - 01/2019
2	venetoclaxIBA 01/2020 - 12/2019
2	Transaminases (Aminotransferases)IBA 05/2012 - 06/2010
1	sacituzumab govitecanIBA 04/2024
1	Hormones (Hormone)IBA 04/2024
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2024
1	remdesivirIBA 11/2023
1	Phosphotransferases (Kinase)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	TCVSIBA 01/2021
1	HhAntag691IBA 01/2021
1	cobimetinibIBA 01/2021
1	Cancer VaccinesIBA 01/2021
1	VemurafenibIBA 01/2021
1	AntigensIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Bendamustine Hydrochloride FDA Link 12/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	obinutuzumabIBA 01/2020
1	Valine (L-Valine)FDA Link 01/2019
1	CitrullineIBA 01/2019
1	3- (4- (2- (2- chloro- 4- fluorophenyl)- 1- (1H- indazol- 5- yl)but- 1- en- 1- yl)phenyl)acrylic acidIBA 10/2018
1	Estrogen ReceptorsIBA 10/2018
1	Bevacizumab (Avastin)FDA Link 08/2016
1	AnthracyclinesIBA 09/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2011
1	Sulfides (Thioethers)IBA 10/2011
1	Maytansine (Maitansine)IBA 10/2011
1	Cytotoxins (Cytolysins)IBA 10/2011
1	Docetaxel (Taxotere)FDA Link 10/2011
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 10/2011
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2011

Therapy/Procedure

6	Therapeutics 01/2020 - 02/2011
5	Drug Therapy (Chemotherapy) 04/2024 - 02/2011
3	Immunotherapy 01/2022 - 01/2018
2	Subcutaneous Injections 04/2022 - 01/2021
1	Duration of Therapy 01/2019